GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (LTS:0KBS) » Definitions » Gross Margin %

Recordati SpA (LTS:0KBS) Gross Margin % : 69.09% (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Recordati SpA Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Recordati SpA's Gross Profit for the three months ended in Sep. 2024 was €385 Mil. Recordati SpA's Revenue for the three months ended in Sep. 2024 was €557 Mil. Therefore, Recordati SpA's Gross Margin % for the quarter that ended in Sep. 2024 was 69.09%.


The historical rank and industry rank for Recordati SpA's Gross Margin % or its related term are showing as below:

LTS:0KBS' s Gross Margin % Range Over the Past 10 Years
Min: 66.88   Med: 69.86   Max: 72.93
Current: 68.03


During the past 13 years, the highest Gross Margin % of Recordati SpA was 72.93%. The lowest was 66.88%. And the median was 69.86%.

LTS:0KBS's Gross Margin % is ranked better than
81.63% of 969 companies
in the Drug Manufacturers industry
Industry Median: 47.02 vs LTS:0KBS: 68.03

Recordati SpA had a gross margin of 69.09% for the quarter that ended in Sep. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Recordati SpA was -0.60% per year.


Recordati SpA Gross Margin % Historical Data

The historical data trend for Recordati SpA's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Gross Margin % Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.52 71.92 72.93 69.42 68.32

Recordati SpA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.12 67.84 68.37 66.84 69.09

Competitive Comparison of Recordati SpA's Gross Margin %

For the Drug Manufacturers - General subindustry, Recordati SpA's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Gross Margin % falls into.



Recordati SpA Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Recordati SpA's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=1422.6 / 2082.331
=(Revenue - Cost of Goods Sold) / Revenue
=(2082.331 - 659.707) / 2082.331
=68.32 %

Recordati SpA's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=385.1 / 557.414
=(Revenue - Cost of Goods Sold) / Revenue
=(557.414 - 172.29) / 557.414
=69.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Recordati SpA  (LTS:0KBS) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Recordati SpA had a gross margin of 69.09% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Recordati SpA Gross Margin % Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA Business Description

Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.

Recordati SpA Headlines

No Headlines